c-erb-A mRNA correlates with T3-receptor levels in liver and pituitary of tumor rats

K. H. Hupart, R. A. Hodin, M. A. Lazar, L. E. Shapiro, W. W. Chin, Martin I. Surks

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

In the rat tumor model of the sick euthyroid syndrome, differential regulation of T3-induced cellular responses have been demonstrated in liver and anterior pituitary. These effects occur with a concomitant decrease in nuclear thyroid hormone receptor (TR) number as measured by the binding of 125I-labeled T3. To explore the possibility that these altered responses to T3 in tumor rats resulted from changes in the expression of different TR forms, we correlated the relative abundance of mRNAs encoding each receptor form with the concentration of TR measured by specific T3 binding. In anterior pituitary of tumor rats, TR β-1 and β-2 mRNA levels decreased to 51 and 45%, respectively, compared to controls; rat c-erb A α-2 mRNA, which encodes a TR-related DNA α-binding protein that does not bind T3, decreased to 46% of control. These findings correlate with a decrease in nuclear T3 binding capacity that has been shown to be 63% of control. The level of TR β-1 mRNA, the only quantifiable TR form in liver, was decreased to 61% of control in the same hepatic tissue that revealed a 50% decrease in TR as measured by specific T3 binding. The coordinate down-regulation of all TR mRNA forms to a degree that parallels the decrease in TR number as measured by specific T3 binding suggests that the differential regulation of T3- mediated effects in illness is by a mechanism other than changing concentrations of specific receptor forms. Additionally, the parallel regulation of TR β mRNAs in the tumor rat contrasts with the opposing regulation of these species with other manipulations, suggesting a novel mode of regulation of the TR.

Original languageEnglish (US)
Pages (from-to)55-58
Number of pages4
JournalThyroid
Volume3
Issue number1
StatePublished - 1993

Fingerprint

Thyroid Hormone Receptors
Pituitary Neoplasms
Messenger RNA
Liver
Euthyroid Sick Syndromes
Neoplasms
DNA-Binding Proteins
Cytoplasmic and Nuclear Receptors
varespladib methyl
Down-Regulation

ASJC Scopus subject areas

  • Endocrinology

Cite this

Hupart, K. H., Hodin, R. A., Lazar, M. A., Shapiro, L. E., Chin, W. W., & Surks, M. I. (1993). c-erb-A mRNA correlates with T3-receptor levels in liver and pituitary of tumor rats. Thyroid, 3(1), 55-58.

c-erb-A mRNA correlates with T3-receptor levels in liver and pituitary of tumor rats. / Hupart, K. H.; Hodin, R. A.; Lazar, M. A.; Shapiro, L. E.; Chin, W. W.; Surks, Martin I.

In: Thyroid, Vol. 3, No. 1, 1993, p. 55-58.

Research output: Contribution to journalArticle

Hupart, KH, Hodin, RA, Lazar, MA, Shapiro, LE, Chin, WW & Surks, MI 1993, 'c-erb-A mRNA correlates with T3-receptor levels in liver and pituitary of tumor rats', Thyroid, vol. 3, no. 1, pp. 55-58.
Hupart KH, Hodin RA, Lazar MA, Shapiro LE, Chin WW, Surks MI. c-erb-A mRNA correlates with T3-receptor levels in liver and pituitary of tumor rats. Thyroid. 1993;3(1):55-58.
Hupart, K. H. ; Hodin, R. A. ; Lazar, M. A. ; Shapiro, L. E. ; Chin, W. W. ; Surks, Martin I. / c-erb-A mRNA correlates with T3-receptor levels in liver and pituitary of tumor rats. In: Thyroid. 1993 ; Vol. 3, No. 1. pp. 55-58.
@article{7f1395365d944adea141409f0ad0511d,
title = "c-erb-A mRNA correlates with T3-receptor levels in liver and pituitary of tumor rats",
abstract = "In the rat tumor model of the sick euthyroid syndrome, differential regulation of T3-induced cellular responses have been demonstrated in liver and anterior pituitary. These effects occur with a concomitant decrease in nuclear thyroid hormone receptor (TR) number as measured by the binding of 125I-labeled T3. To explore the possibility that these altered responses to T3 in tumor rats resulted from changes in the expression of different TR forms, we correlated the relative abundance of mRNAs encoding each receptor form with the concentration of TR measured by specific T3 binding. In anterior pituitary of tumor rats, TR β-1 and β-2 mRNA levels decreased to 51 and 45{\%}, respectively, compared to controls; rat c-erb A α-2 mRNA, which encodes a TR-related DNA α-binding protein that does not bind T3, decreased to 46{\%} of control. These findings correlate with a decrease in nuclear T3 binding capacity that has been shown to be 63{\%} of control. The level of TR β-1 mRNA, the only quantifiable TR form in liver, was decreased to 61{\%} of control in the same hepatic tissue that revealed a 50{\%} decrease in TR as measured by specific T3 binding. The coordinate down-regulation of all TR mRNA forms to a degree that parallels the decrease in TR number as measured by specific T3 binding suggests that the differential regulation of T3- mediated effects in illness is by a mechanism other than changing concentrations of specific receptor forms. Additionally, the parallel regulation of TR β mRNAs in the tumor rat contrasts with the opposing regulation of these species with other manipulations, suggesting a novel mode of regulation of the TR.",
author = "Hupart, {K. H.} and Hodin, {R. A.} and Lazar, {M. A.} and Shapiro, {L. E.} and Chin, {W. W.} and Surks, {Martin I.}",
year = "1993",
language = "English (US)",
volume = "3",
pages = "55--58",
journal = "Thyroid",
issn = "1050-7256",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - c-erb-A mRNA correlates with T3-receptor levels in liver and pituitary of tumor rats

AU - Hupart, K. H.

AU - Hodin, R. A.

AU - Lazar, M. A.

AU - Shapiro, L. E.

AU - Chin, W. W.

AU - Surks, Martin I.

PY - 1993

Y1 - 1993

N2 - In the rat tumor model of the sick euthyroid syndrome, differential regulation of T3-induced cellular responses have been demonstrated in liver and anterior pituitary. These effects occur with a concomitant decrease in nuclear thyroid hormone receptor (TR) number as measured by the binding of 125I-labeled T3. To explore the possibility that these altered responses to T3 in tumor rats resulted from changes in the expression of different TR forms, we correlated the relative abundance of mRNAs encoding each receptor form with the concentration of TR measured by specific T3 binding. In anterior pituitary of tumor rats, TR β-1 and β-2 mRNA levels decreased to 51 and 45%, respectively, compared to controls; rat c-erb A α-2 mRNA, which encodes a TR-related DNA α-binding protein that does not bind T3, decreased to 46% of control. These findings correlate with a decrease in nuclear T3 binding capacity that has been shown to be 63% of control. The level of TR β-1 mRNA, the only quantifiable TR form in liver, was decreased to 61% of control in the same hepatic tissue that revealed a 50% decrease in TR as measured by specific T3 binding. The coordinate down-regulation of all TR mRNA forms to a degree that parallels the decrease in TR number as measured by specific T3 binding suggests that the differential regulation of T3- mediated effects in illness is by a mechanism other than changing concentrations of specific receptor forms. Additionally, the parallel regulation of TR β mRNAs in the tumor rat contrasts with the opposing regulation of these species with other manipulations, suggesting a novel mode of regulation of the TR.

AB - In the rat tumor model of the sick euthyroid syndrome, differential regulation of T3-induced cellular responses have been demonstrated in liver and anterior pituitary. These effects occur with a concomitant decrease in nuclear thyroid hormone receptor (TR) number as measured by the binding of 125I-labeled T3. To explore the possibility that these altered responses to T3 in tumor rats resulted from changes in the expression of different TR forms, we correlated the relative abundance of mRNAs encoding each receptor form with the concentration of TR measured by specific T3 binding. In anterior pituitary of tumor rats, TR β-1 and β-2 mRNA levels decreased to 51 and 45%, respectively, compared to controls; rat c-erb A α-2 mRNA, which encodes a TR-related DNA α-binding protein that does not bind T3, decreased to 46% of control. These findings correlate with a decrease in nuclear T3 binding capacity that has been shown to be 63% of control. The level of TR β-1 mRNA, the only quantifiable TR form in liver, was decreased to 61% of control in the same hepatic tissue that revealed a 50% decrease in TR as measured by specific T3 binding. The coordinate down-regulation of all TR mRNA forms to a degree that parallels the decrease in TR number as measured by specific T3 binding suggests that the differential regulation of T3- mediated effects in illness is by a mechanism other than changing concentrations of specific receptor forms. Additionally, the parallel regulation of TR β mRNAs in the tumor rat contrasts with the opposing regulation of these species with other manipulations, suggesting a novel mode of regulation of the TR.

UR - http://www.scopus.com/inward/record.url?scp=0027267039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027267039&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 55

EP - 58

JO - Thyroid

JF - Thyroid

SN - 1050-7256

IS - 1

ER -